Dr. Borinstein is the Scott and Tracie Hamilton Chair in Cancer Survivorship in the Division of Pediatric Hematology/Oncology at Vanderbilt University Medical Center. He is the director of the Pediatric Sarcoma and Adolescent and Young Adult (AYA) oncology programs, serves as the Pediatric Hematology/Oncology fellowship Program Director, and is the local institutional principal investigator for the Children's Oncology Group. He is a nationally recognized expert in bone and soft tissue sarcomas and his research and clinical interests are aligned to improve the treatment and outcomes of children, teenagers, and young adults with cancer. In addition to conducting translational research in pediatric sarcomas, highly malignant cancers of bone, muscle, and connective tissue. Dr. Borinstein is involved in the development and implementation of clinical trials for solid tumors and AYA cancer patients, with a goal of integrating new drugs and protocols into our current cancer therapies. Dr. Borinstein also is also actively involved in developing ways to improve supportive care and minimize late effects for AYA patients during and after being treated with cancer.

>> View Publications on PubMed